Investor Societe des Produits Nestle S.A.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Societe des Produits Nestle S.A. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2023-02-02 13G/A AXLA / Axcella Health Inc. 4,305,541 11,105,438
2022-10-19 13G CDXC / ChromaDex Corporation 3,816,794
2021-02-12 13G/A AXLA / Axcella Health Inc. 4,305,541
2020-10-13 13D/A 0HBB / Aimmune Therapeutics Inc 12,813,247 100
2020-08-31 13D/A 0HBB / Aimmune Therapeutics Inc 12,813,247